Φορτώνει......
Immune therapy for treating type 1 diabetes: challenging existing paradigms
Patients with type 1 diabetes (T1D) rapidly lose β cell function and/or mass, leading to a life-long dependence on insulin therapy. β Cell destruction is mediated by aberrant immune responses; therefore, immune modulation has potential to ameliorate disease. While immune intervention in animal model...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Clin Invest |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Society for Clinical Investigation
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382231/ https://ncbi.nlm.nih.gov/pubmed/25500880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI79190 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|